Landiolol
CAS 133242-30-5Small Molecule
Overview
Landiolol is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1742466).
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Landiolol expires 25 Apr 2034 and exclusivity 22 Nov 2029. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- [(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl 3-[4-[(2S)-2-hydroxy-3-[2-(morpholine-4-carbonylamino)ethylamino]propoxy]phenyl]propanoate
- Canonical SMILES
- CC1(OC[C@H](O1)COC(=O)CCC2=CC=C(C=C2)OC[C@H](CNCCNC(=O)N3CCOCC3)O)C
- InChIKey
- WMDSZGFJQKSLLH-RBBKRZOGSA-N
Verified Supplier Partner
Do you supply Landiolol? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.